NCT04182984 2026-01-30
TREAT-OMG
Tang-Du Hospital
Recruiting
Clinical Trials
11 trialsNCT05959720 2025-05-07
BRALLA
Instituto do Cancer do Estado de São Paulo
Recruiting
NCT06652607 2025-03-12
PSA-DEEP02
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT05899621 2023-06-12
A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL
Ruijin Hospital
Recruiting
NCT05188911 2022-01-12
Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial
Fudan University
Unknown
NCT04101578 2021-08-23
Clinical Prognosis and Progression of Myasthenia Gravis Patients
Da, Yuwei, M.D.
Unknown
NCT04768465 2021-02-24
Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis
Da, Yuwei, M.D.
Unknown
NCT01540812 2020-03-09
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS
PETHEMA Foundation
Completed
NCT00900445 2018-08-07
Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia
Children's Oncology Group
Withdrawn
NCT01692483 2015-12-02
Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Janssen Pharmaceutica
Withdrawn
NCT02474563 2015-06-30
Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma
Janssen Korea, Ltd., Korea
Completed